Clin Breast Cancer. 2003 Feb;3 Suppl 4:S158-63.

Fusions of breast cancer and dendritic cells as a novel cancer vaccine.

Source

Bone Marrow Transplantation and Hematological Malignancies, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. mavigan@aol.com

Abstract

The use of dendritic cell (DC)-based cancer vaccines has emerged as a promising area of investigation in the field of tumor immunotherapy. DCs are potent antigen-presenting cells that are essential for the initiation of primary immune responses. DCs that have been manipulated to express tumor antigens are capable of stimulating tumor-specific immunity. The fusion of tumor cells with DCs results in the presentation of a broad spectrum of tumor antigens in the context of the immune-stimulating machinery of the DC. Animal models have demonstrated that vaccination with DC/tumor fusions is protective from a lethal challenge with tumor cells and results in regression of established disease. Preclinical human studies in breast cancer have shown that fusion cells stimulate cellular immune responses capable of lysing autologous tumor cells. Based on these findings, a phase I clinical trial has been conducted in patients with metastatic breast cancer to examine the toxicity profile and immunologic impact associated with vaccination with DC/tumor fusions.

PMID:: 12620154; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Cancer Vaccines

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Breast Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Dendritic cell fusion vaccines for cancer immunotherapy. [Expert Opin Biol Ther. 2005]
Review Dendritic cell fusion vaccines for cancer immunotherapy.
Rosenblatt J, Kufe D, Avigan D. Expert Opin Biol Ther. 2005 May; 5(5):703-15.
Review Dendritic cell-tumor fusion vaccines for renal cell carcinoma. [Clin Cancer Res. 2004]
Review Dendritic cell-tumor fusion vaccines for renal cell carcinoma.
Avigan D. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 2):6347S-52S.
Review Dendritic/tumor fusion cell-based vaccination against cancer. [Arch Immunol Ther Exp (Warsz)....]
Review Dendritic/tumor fusion cell-based vaccination against cancer.
Koido S, Hara E, Homma S, Fujise K, Gong J, Tajiri H. Arch Immunol Ther Exp (Warsz). 2007 Sep-Oct; 55(5):281-7.
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses. [Clin Cancer Res. 2004]
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.
Avigan D, Vasir B, Gong J, Borges V, Wu Z, Uhl L, Atkins M, Mier J, McDermott D, Smith T, et al. Clin Cancer Res. 2004 Jul 15; 10(14):4699-708.
Review Cancer vaccine by fusions of dendritic and cancer cells. [Clin Dev Immunol. 2009]
Review Cancer vaccine by fusions of dendritic and cancer cells.
Koido S, Hara E, Homma S, Namiki Y, Ohkusa T, Gong J, Tajiri H. Clin Dev Immunol. 2009; 2009:657369. Epub 2010 Feb 18.

See reviews... See all...

Cited by 2 PubMed Central articles

Dendritic cell-Ewing's sarcoma cell hybrids enhance antitumor immunity. [Clin Orthop Relat Res. 2008]
Dendritic cell-Ewing's sarcoma cell hybrids enhance antitumor immunity.
Guo W, Guo Y, Tang S, Qu H, Zhao H. Clin Orthop Relat Res. 2008 Sep; 466(9):2176-83. Epub 2008 Jun 19.
In vivo anti-tumor effect of hybrid vaccine of dendritic cells and esophageal carcinoma cells on esophageal carcinoma cell line 109 in mice with severe combined immune deficiency. [World J Gastroenterol. 2008]
In vivo anti-tumor effect of hybrid vaccine of dendritic cells and esophageal carcinoma cells on esophageal carcinoma cell line 109 in mice with severe combined immune deficiency.
Guo GH, Chen SZ, Yu J, Zhang J, Luo LL, Xie LH, Su ZJ, Dong HM, Xu H, Wu LB. World J Gastroenterol. 2008 Feb 28; 14(8):1167-74.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Fusions of breast cancer and dendritic cells as a novel cancer vaccine.
Fusions of breast cancer and dendritic cells as a novel cancer vaccine.
Clin Breast Cancer. 2003 Feb ;3 Suppl 4:S158-63.

PubMed
Genesis and evolution of the Evx and Mox genes and the extended Hox and ParaHox ...
Genesis and evolution of the Evx and Mox genes and the extended Hox and ParaHox gene clusters.
Genome Biol. 2003 ;4(2):R12. Epub 2003 Jan 23 .

PubMed
Identification of expressed genes linked to malignancy of human colorectal carci...
Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data.
Genome Biol. 2003 ;4(3):R21. Epub 2003 Feb 27 .

PubMed
Interaction of body mass index and attempt to lose weight in a national sample o...
Interaction of body mass index and attempt to lose weight in a national sample of US adults: association with reported food and nutrient intake, and biomarkers.
Eur J Clin Nutr. 2003 Feb ;57(2):249-59.

PubMed
NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.
NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.
Nature. 2003 Feb 6 ;421(6923):639-43.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: